DeFi Development Corp. (DFDV) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US47100L3015
DeFi Development Corp. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 11.39 m USD |
| Gross profit | 11.14 m USD |
| Operating income | -36.40 m USD |
| EBIT | -64.85 m USD |
| Net income | -73.79 m USD |
| Diluted EPS – continuing operations | -4.00 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About DeFi Development Corp.
DeFi Development Corp. focuses on building its treasury around Solana (SOL). SOL is a blockchain infrastructure platform. The company operates through two segments: Digital Asset Treasury and Real Estate Platform. The Digital Asset Treasury segment executes and manages its treasury policy for the purpose of purchasing, holding, and compounding its digital asset holdings through staking and operating its owned validators. The Real Estate Platform segment offers a technology platform that connects commercial mortgage and small business borrowers looking for debt to refinance, build, or buy commercial property, including apartment buildings and commercial property lenders. The company was formerly known as Janover Inc. and changed its name to DeFi Development Corp. in April 2025. The company. was founded in 2018 and is headquartered in Boca Raton, Florida.
More stocks
- ANAVEX LIFE SCIENCES CORP. (AVXL)
- Bunker Hill Mining Corp. (BHLL)
- CAPITAL PROPERTIES INC /RI/ (CPTP)
- JOINT Corp (JYNT)
- Alan Allman Associates SA (AAA.PA)
- eWork Group AB (EWRK.ST)
- Western Asset Investment Grade Defined Opportunity Closed Fund (IGI)
- Telechips Inc (054450.KQ)
- BRC Inc. (BRCC)
- PMV Pharmaceuticals, Inc. (PMVP)
- Polynet PCL (POLY.BK)
- Spyrosoft S.A. (SPR.WA)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.